July 24, 2023
The Japanese health ministry on July 20 presented the number of health damages reported for regenerative medicine products between October 2022 and March 2023, with JCR Pharmaceuticals’ mesenchymal stem cell therapy Temcell logging the highest figure at 93. In the...read more